<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">The article published online on 19th February, draws its results from a clinical trial conducted in more than ten Chinese hospitals (in Wuhan - epicenter of the epidemic -, Beijing and Shanghai in particular) to measure the effectiveness of chloroquine on treatment of pneumonia associated with Covid-19 [
 <xref rid="bib13" ref-type="bibr">13</xref>]. In this study, it was confirmed that the anti-viral and anti-inflammatory activities of chloroquine may account for its potent efficacy in treating patients with COVID-19 pneumonia. According to Chinese researchers, a treatment of 500 mg of chloroquine per day for ten days would be sufficient. According to Chinese researchers, a treatment of 500 mg of chloroquine per day for ten days would be sufficient.
</p>
